Users' questions

What is Irma test?

What is Irma test?

This test is useful for detecting over 90 known and novel mutations in ABL kinase domain of Ph chromosome including T3151 and P-loop mutations responsible for resistance to Imatinib in CML patients.

What is T315I mutation?

Discussion. T315I mutation is a single base substitution act>att resulting in a threonine-to-isoleucine exchange at amino acid position 315 on BCR-ABL1 kinase domain.

What is BCR ABL mutation?

BCR-ABL is a mutation that is formed by the combination of two genes, known as BCR and ABL. It’s sometimes called a fusion gene. The BCR gene is normally on chromosome number 22. The ABL gene is normally on chromosome number 9. The BCR-ABL mutation happens when pieces of BCR and ABL genes break off and switch places.

When to test for BCR-ABL1 t3151 mutation?

BCR-ABL1 kinase domain mutation testing is recommended to guide choice of second-line TKI therapy. The BCR-ABL1 T3151 mutation imparts resistance to all currently approved TKIs. Content in tables below based on Cortes J, 2011; Hochhaus A, 2011; Hughes, 2009; Kantarjian H, 2007; Saglio G, 2012; Yeung, 2011.

Are there any patients with the T315I mutation?

A total of 38 (18%) patients harbored the T315I mutation in this period. According to the type of salvage therapy, patients were divided into subgroups of hematopoietic stem cell transplantation (HSCT) recipients (n = 9) and HSCT nonrecipients (n = 29).

Which is the mutation that imparts resistance to TKIs?

A 5- to 10-fold increase in the levels of BCR-ABL1 fusion transcripts by quantitative PCR suggests resistance. BCR-ABL1 kinase domain mutation testing is recommended to guide choice of second-line TKI therapy. The BCR-ABL1 T3151 mutation imparts resistance to all currently approved TKIs.

Are there any clinical trials with ABL1 T315I?

ABL1 T315I serves as an inclusion eligibility criterion in 7 clinical trials, of which 6 are open and 1 is closed. Of the trials that contain ABL1 T315I as an inclusion criterion, 2 are phase 1 (1 open), 2 are phase 1/phase 2 (2 open), 2 are phase 2 (2 open), and 1 is phase 3 (1 open).